antivir
action
chloroxylenol
benzalkonium
chlorid
cetrimidechlorhexidin
assess
rang
envelop
nonenvelop
human
virus
use
suspens
test
method
viral
suspens
pfutcid
sfu
prepar
antisept
disinfect
solut
presenc
bovin
serumyeast
extract
mixtur
simul
dirti
condit
incub
aliquot
remov
predctermincd
timepoint
io
min
assess
kinet
inactiv
result
indic
product
effect
inactiv
envelop
virus
herp
simplex
viru
type
human
immunodehci
viru
type
whilst
ineffect
inactiv
human
coronaviru
also
envelop
noncnvelopcd
virus
except
benzalkonium
chloridebas
product
dettol
hospit
concentr
activ
nonenvelop
human
coxsacki
viru
four
antisepticdisinfect
solut
chloroxylenol
benzalkonium
chlorid
cetrimid
chlorhexidin
povidoneiodin
also
assess
antivir
effect
human
immunodefici
viru
presenc
whole
human
blood
four
solut
prove
effect
within
min
despit
cytotox
natur
compound
detect
system
specif
guidelin
test
effici
antimicrobi
agent
bacteria
gener
accept
guidelin
test
effici
virus
guidanc
issu
german
feder
health
offic
test
effect
chemic
disinfect
virus
two
commonli
use
method
valid
antivir
activ
antimicrobi
agent
suspens
surfac
test
suspens
test
involv
exposur
known
viru
titr
agent
time
determin
amount
infect
vriru
remain
end
incub
normal
condit
includ
incub
time
min
room
surfac
test
involv
dri
viral
suspens
known
titr
hard
porou
surfac
expos
surfac
germicid
requir
length
time
order
accur
test
effect
antisepticdisinfect
real
situat
dirti
condit
simul
use
serum
yeast
suspens
test
util
sever
studi
particular
comparison
antimicrobi
agent
herp
simplex
viru
hsv
human
immunodefici
viru
hiv
assess
aim
studi
assess
antivir
natur
group
antisepticdisinfect
rang
envelop
nonenvelop
human
virus
methodolog
employ
base
protocol
european
disinfect
test
bactericid
activ
cen
technic
committe
specif
call
phase
step
test
disinfect
product
use
surfac
medic
area
activ
ingredi
product
test
chloroxylenol
benzalkonium
chlorid
cetrimidechlorhexidin
use
throughout
world
skin
antisepsi
blood
spillag
pose
infect
risk
hiv
studi
also
investig
antivir
effect
agent
alreadi
mention
togeth
iodophor
povidoneiodin
hiv
presenc
whole
human
blood
tissu
c
cell
media
media
suppli
life
technolog
supplement
fetal
calf
serum
penicillinstreptomycin
ljmlso
pgml
nonessenti
amino
acid
vero
african
green
monkey
kidney
cell
grown
glutamax
fetal
calf
serum
hela
technolog
ad
final
concentr
hard
water
dilut
product
solut
contain
g
anhydr
mgclz
g
anhydr
cacl
dilut
purifi
water
dilut
deioniz
water
steril
min
solut
b
contain
g
nahco
dilut
l
deioniz
water
steril
urn
membran
filtrat
purifi
water
ml
ml
solut
ml
solut
b
mix
dilut
l
deioniz
water
final
water
hard
test
ppm
caco
ph
bovin
serum
albuminyeast
extract
bovin
serum
albumin
w
v
sigma
chemic
prepar
deioniz
water
steril
urn
membran
filtrat
yeast
extract
wv
oxoid
p
are
deioniz
water
autoclav
c
p
min
ph
adjust
equal
quantiti
bovin
serum
albumin
yeast
extract
solut
mix
provid
combin
organ
soil
load
wv
antisepticldisinfect
neutral
system
test
antisepticdisinfect
solut
reaction
neutral
system
assess
cytotox
effect
detector
cell
line
except
cell
aliquot
solut
serial
iofold
dilut
inocul
onto
confluent
monolay
cell
steril
linbro
well
cell
cultur
plate
ml
per
well
incub
min
inocula
remov
cell
wash
phosphatebuff
salin
ml
cell
mainten
medium
ad
per
well
cell
observ
period
seven
day
gener
condit
round
granular
cell
death
note
solut
cytotox
cytotox
mostli
confin
undilut
product
concentr
test
cell
line
presenc
whole
human
blood
concentr
product
cytotox
detector
cell
line
observ
hibicet
hospit
concentr
lyse
red
blood
cell
dilut
neutral
system
gru
activ
order
ensur
neutral
system
antivir
virus
emplov
studi
control
perform
neutral
medium
challeng
separ
viru
incub
min
neutral
time
end
incub
period
sampl
assay
viru
infect
addit
neutral
medium
challeng
human
immunodehci
viru
type
presenc
whole
blood
treat
describ
previous
neutral
system
also
check
ensur
neutral
antisepticdisinfect
product
test
materi
prepar
x
concentr
vvater
standard
hard
allow
dilut
occur
addit
inorgan
soil
one
millilitr
bovin
serum
albuminyeast
extract
mixtur
ad
ml
dilut
test
materi
distil
water
ml
distil
water
incub
k
c
min
one
millilitr
aliquot
remov
ad
ml
neutral
medium
incub
min
effect
neutral
one
millilitr
viru
challeng
dilut
give
final
concentr
approxim
tcid
ml
pfuml
sfuml
pfu
plaqueform
unit
sfu
syncytiaform
unit
ad
min
ca
c
sampl
assay
viru
infect
appropri
detector
cell
tcid
plaqu
syncytiaform
assay
human
blood
experi
test
materi
prepar
x
concentr
water
standard
hard
except
betadin
one
millilitr
whole
human
blood
ad
ml
dilut
test
materi
distil
water
ml
distil
water
incub
min
one
millilitr
aliquot
remov
ad
ml
neutral
medium
incub
min
f
c
effect
neutral
one
millilitr
human
immunodefici
viru
type
dilut
give
final
concentr
approxim
sfuml
ad
mink
sampl
assess
viru
infect
syncytiaform
assay
whole
human
blood
experi
test
matrial
prepar
x
concentr
water
standard
hard
except
betadin
five
millilitr
whole
human
blood
ad
ml
dilut
test
materi
distil
water
ml
distil
water
incub
min
sampl
treat
describ
previous
whole
human
blood
experi
virucid
activ
antisepticdisinfect
presenc
albumin
yeast
extract
virucid
activ
dettol
dettol
hospit
concentr
savlon
compar
water
standard
hard
test
virus
test
product
dilut
water
standard
hard
initi
x
concentraion
allow
dilut
occur
inorgan
soil
viru
challeng
ad
one
millilitr
bovin
serum
albuminyeast
extract
mixtur
ad
dilut
test
product
hard
water
mix
l
c
ml
viru
challeng
ad
one
millilitr
aliquot
remov
min
ad
ml
neutral
medium
ml
water
standard
hard
neutral
mink
neutral
sampl
assay
viru
infect
appropri
detector
cell
tcidso
plaqu
syncytiaform
assay
virucid
activ
antisepticdisinfect
presenc
whole
human
blood
dettol
dettol
hospit
concentr
hibicet
hospit
concentr
betadin
antisept
solut
assess
virucid
action
human
immunodefici
viru
type
presenc
whole
human
blood
test
presenc
blood
solut
except
betadin
dilut
water
standard
hard
initi
x
concentr
eight
millilitr
mix
ml
whole
human
blood
challeng
ml
human
immunodefici
viru
type
betadin
suppli
readytous
product
ml
undilut
product
use
give
final
concentr
vv
test
presenc
whole
human
blood
solut
except
betadin
dilut
water
standard
hard
initi
x
concentr
four
millilitr
mix
ml
whole
human
blood
challeng
ml
human
immunodefici
viru
type
betadin
ml
undilut
product
use
give
final
concentr
one
millilitr
aliquot
reaction
mixtur
remov
min
ad
ml
neutral
medium
ml
water
standard
hard
min
neutral
sampl
assay
viru
infect
detector
cell
line
syncytiaform
assay
water
standard
hard
replac
antisepticdisinfect
whole
human
blood
concent
act
control
evalu
effect
neutral
system
inactiv
product
assess
system
viru
activ
neutral
system
significantli
antivir
virus
use
challeng
studi
tabl
ii
neutral
system
determin
effect
inactiv
product
differ
viru
titr
recov
within
log
water
control
product
condit
challeng
virus
tabl
iii
iv
dirti
condit
antisept
product
effect
envelop
virus
herp
simplex
viru
type
human
immunodefici
viru
type
within
min
except
savlon
versu
human
immunodefici
viru
type
inact
min
activ
min
tabl
v
reduct
factor
obtain
viru
detect
underestim
inactiv
potenti
disinfectantsantisept
due
cytotox
effect
decreas
sensit
level
detect
system
reduct
factor
log
indic
good
antivir
system
reduct
log
suggest
moder
antivir
effect
consider
must
made
cytotox
effect
product
detect
system
result
consist
investig
inactiv
virus
deterg
antisept
effect
inactiv
resist
nonenvelop
polioviru
sabin
type
human
adenoviru
coxsacki
viru
envelop
human
coronaviru
even
min
timepoint
except
dettol
hospit
concentr
activ
agent
benzalkonium
chlorid
effect
inactiv
nonenvelop
human
coxsacki
viru
reduct
log
min
timepoint
whole
human
blood
antisepticdisinfect
dettol
dettol
hospit
concentr
betadin
antisept
solut
hibicet
hospit
concentr
effect
inactiv
human
immunodefici
viru
presenc
whole
human
blood
within
min
tabl
vi
hibicet
hospit
concentr
test
presenc
blood
hospit
product
wherea
savlon
deliv
similar
level
activ
ingredi
recommend
dilut
domest
usag
hibicet
hospit
concentr
inactiv
human
immunodefici
viru
type
within
min
compar
min
inactiv
time
savlon
presenc
albuminyeast
mixtur
faster
inactiv
hibicet
hospit
concentr
may
due
slightli
higher
concentr
activ
ingredi
present
comparison
savlon
lack
protect
effect
blood
product
lyse
albuminyeast
mixtur
savlon
experi
provid
protect
effect
toward
viru
particl
prevent
rapid
inactiv
limit
effect
phenol
disinfect
viru
inactiv
nonvirucid
effect
cetrimidechlorhexidin
antisept
nonenvelop
ii
virus
also
demonstr
narang
codd
extens
studi
grossgebau
indic
quaternari
ammonium
product
adsorb
protein
subsequ
inactiv
whilst
activ
lipophil
virus
eg
herp
simplex
vaccinia
influenza
adenoviru
less
effect
hydrophil
virus
enteroviru
eg
polioviru
coxsacki
echo
demonstr
quaternari
ammonium
product
rapidli
inactiv
strain
coxsacki
viru
room
temperatur
presenc
organ
soil
viricid
activ
depend
upon
concentr
activ
ingredi
ph
condit
within
reaction
mixtur
appear
allow
inactiv
occur
quaternari
ammonium
compound
surfac
act
agent
inactiv
may
due
alter
surfac
compon
adjac
attach
site
interact
receptor
surfac
host
cell
conclus
solut
test
recommend
concentr
antisept
use
effect
inactiv
nonenvelop
virus
human
immunodefici
viru
type
herp
simplex
viru
type
presenc
signific
level
organ
soil
product
could
use
infect
control
programm
hospit
commun
particularli
develop
countri
mani
patient
latter
includ
human
immunodefici
viru
posit
care
commun
famili
antisept
combin
good
bacteri
activ
enter
organ
antivir
activ
could
prevent
spread
infect
area
product
dettol
savlon
wide
avail
world
low
toxic
good
safeti
record
recommend
use
nonhealth
profession
